{"product_id":"lucilorlalorlatinib-люсилорла-лорлатиниб","title":"LuciLorla(Lorlatinib)               ЛюсиЛорла (Лорлатиниб)","description":"\u003cp class=\"x1yc453h x1hpqcdg x1ekroe6 xutxfr x1fie51u xgyxj25 xkyrhof x1elgs31 x1fv8qjw x1tbvfm1 xb72syl x1iew0xx x1c2l018 x14l7nz5 xuw7688 x1pjt2rx x160d6zm xrxpjvj\" dir=\"ltr\"\u003e\u003cstrong class=\"x1s688f\"\u003eLuciLorla (Lorlatinib)\u003c\/strong\u003e is a targeted anticancer medicine containing lorlatinib, a selective inhibitor of ALK (anaplastic lymphoma kinase) and ROS1 tyrosine kinases. Lorlatinib is designed to block abnormal signaling pathways that can contribute to the growth and spread of cancer cells.\u003c\/p\u003e\n\u003cp class=\"x1yc453h x1hpqcdg x1ekroe6 xutxfr x1fie51u xgyxj25 xkyrhof x1elgs31 x1fv8qjw x1tbvfm1 xb72syl x1iew0xx x1c2l018 x14l7nz5 xuw7688 x1pjt2rx x160d6zm xrxpjvj\" dir=\"ltr\"\u003eLorlatinib is used for the treatment of certain patients with \u003cstrong class=\"x1s688f\"\u003eALK-positive metastatic non-small cell lung cancer (NSCLC)\u003c\/strong\u003e. It may be used when the tumor contains an ALK alteration identified through appropriate molecular testing and according to approved treatment indications.\u003c\/p\u003e\n\u003cp class=\"x1yc453h x1hpqcdg x1ekroe6 xutxfr x1fie51u xgyxj25 xkyrhof x1elgs31 x1fv8qjw x1tbvfm1 xb72syl x1iew0xx x1c2l018 x14l7nz5 xuw7688 x1pjt2rx x160d6zm xrxpjvj\" dir=\"ltr\"\u003eLuciLorla is an oral medicine intended for use under the supervision of a qualified healthcare professional. The appropriate dosage, treatment duration, monitoring, and management of potential adverse reactions or drug interactions should be determined by the treating physician.\u003c\/p\u003e\n\u003cp class=\"x1yc453h x1hpqcdg x1ekroe6 xutxfr x1fie51u xgyxj25 xkyrhof x1elgs31 x1fv8qjw x1tbvfm1 xb72syl x1iew0xx x1c2l018 x14l7nz5 xuw7688 x1pjt2rx x160d6zm xrxpjvj\" dir=\"ltr\"\u003eProduct strength, packaging, manufacturer, availability, and regulatory status may vary depending on the market and specific product presentation. Healthcare professionals should consult the applicable official prescribing information before prescribing or dispensing this medicine.\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":48914900680747,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/bvc.webp?v=1789763422","url":"https:\/\/xomeds.com\/ru\/products\/lucilorlalorlatinib-%d0%bb%d1%8e%d1%81%d0%b8%d0%bb%d0%be%d1%80%d0%bb%d0%b0-%d0%bb%d0%be%d1%80%d0%bb%d0%b0%d1%82%d0%b8%d0%bd%d0%b8%d0%b1","provider":"XOMEDS","version":"1.0","type":"link"}